We are open with limited hours and staff.
Price range: $159.00 through $707.00
OXYCONTIN contains extended-release oxycodone and is prescribed for severe, persistent pain that requires opioid treatment when alternative options are inadequate. Unlike immediate-release oxycodone, OXYCONTIN is designed for longer-lasting medication release and is not intended for as-needed pain relief.
In contrast, 5mg oxycodone hydrochloride tablets are available as immediate-release prescription opioid medicines. These products should not be confused with OXYCONTIN simply because both contain oxycodone. Formulation, strength, release characteristics, and labeling can differ significantly.
Consequently, patients should verify the exact medication name, strength, manufacturer, and formulation with a pharmacist or other qualified healthcare professional before using any oxycodone product.
Oxycodone products carry important warnings involving addiction, abuse, misuse, overdose, and potentially life-threatening respiratory depression. These risks can occur even when an opioid is used according to a prescription. For that reason, treatment should remain under appropriate medical supervision.
Common opioid-related effects may include drowsiness, dizziness, nausea, constipation, and sedation. However, unusually slow or difficult breathing can indicate a medical emergency and requires immediate attention.
Furthermore, combining oxycodone with alcohol, benzodiazepines, or other central nervous system depressants can increase the risk of profound sedation, respiratory depression, coma, and death. Patients should tell their healthcare professional about all medicines and substances they use.
Patients should use oxycodone only as prescribed and should never change the dose or formulation independently. Extended-release oxycodone tablets must be swallowed whole; crushing, chewing, breaking, or dissolving them can increase oxycodone exposure and overdose risk.
Prescription opioids should also be stored securely and never shared with another person. Additionally, patients who have developed physical dependence should not abruptly discontinue treatment. A healthcare professional can provide appropriate guidance for gradual dose reduction when treatment needs to end.
